Orexigen Therapeutics, Inc.

A drug company’s risk of receiving a promotion enforcement letter from the US Food and Drug Administration may increase with corporate mergers and acquisitions and a failure to clear away old advertis

A Lesser-Appreciated Pandemic Legacy Investors in companies like Pfizer Inc. * and Roche Holding AG have discovered that developing vaccines, drugs and diagnostics that helped resolve the pandemic

The Centers for Medicare and Medicaid Services is leaning toward changing the drug classification standard for private insurance plans serving the individual and small group markets in a way that coul

The European Medicines Agency wants to know how many patients worldwide have used Currax Pharmaceuticals ’ weight management drug, Mysimba (naltrexone/bupropion), as part of a safety review it has st